Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B
Clinical trial NCT00128544 · COMPLETED
Trial details
- NCT number
- NCT00128544
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2007-05-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.